Nuclear Factor of Activated T Cells C1 Induces Osteoclast-associated Receptor Gene Expression During Tumor Necrosis Factor-related Activation-induced Cytokine-mediated Osteoclastogenesis
Overview
Authors
Affiliations
Osteoclast differentiation from hematopoietic precursors is controlled by the tumor necrosis factor family member tumor necrosis factor-related activation-induced cytokine (TRANCE) via induction of various transcription factors, including nuclear factor of activated T cells (NFAT) c1. During osteoclast differentiation, NFATc1 is further activated via calcium signaling when costimulatory receptors expressed on osteoclast precursors, such as osteoclast-associated receptor (OSCAR), are stimulated. Here we show that NFATc1 expression precedes that of OSCAR during TRANCE-mediated osteoclastogenesis and that inhibition of NFATc1 by cyclosporin A abolishes TRANCE-induced OSCAR expression and subsequent osteoclast differentiation. Moreover, we show that the 1.0-kb promoter region of the OSCAR gene contains three potential NFATc1-binding sites. Induction of an OSCAR promoter-luciferase reporter is significantly increased when transiently transfected into 293T cells in combination with NFATc1 expression plasmid. Deletion and site-directed mutant constructs confirmed that NFATc1-binding sites are both functional and NFATc1-specific. Furthermore, NFATc1 synergistically activates an OSCAR reporter construct together with microphthalmia transcription factor and PU.1, transcription factors previously shown to be critical for osteoclast differentiation. In addition, a plasmid expressing constitutively active MAP kinase kinase 6 enhances the transactivation activity of NFATc1/microphthalmia transcription factor/PU.1 on the OSCAR promoter. Taken together, our results indicate that NFATc1 is an important transcription factor in the induction of OSCAR during osteoclastogenesis. Elucidation of NFATc1 as a transcription factor for OSCAR expression implies the presence of a positive feedback circuit of TRANCE-induced activation of NFATc1, involving NFATc1-mediated OSCAR expression and its subsequent activation of NFATc1, necessary for efficient differentiation of osteoclasts.
Heme oxygenase-1: potential therapeutic targets for periodontitis.
Lv W, Hu S, Yang F, Lin D, Zou H, Zhang W PeerJ. 2024; 12:e18237.
PMID: 39430558 PMC: 11488498. DOI: 10.7717/peerj.18237.
Xie G, Huang C, Jiang S, Li H, Gao Y, Zhang T J Orthop Translat. 2024; 46:33-45.
PMID: 38765605 PMC: 11101877. DOI: 10.1016/j.jot.2024.04.003.
Cohen D, Dennis C, Deng J, Boyan B, Schwartz Z JBMR Plus. 2024; 8(5):ziae041.
PMID: 38644978 PMC: 11032217. DOI: 10.1093/jbmrpl/ziae041.
Yang J, Sun B, Wang Z, Li X, Gao J, Qian J Cell Death Dis. 2023; 14(11):738.
PMID: 37957146 PMC: 10643436. DOI: 10.1038/s41419-023-06263-4.
Material matters: exploring the interplay between natural biomaterials and host immune system.
Tripathi A, Zaki M, Al-Hussain S, Dubey B, Singh P, Rind L Front Immunol. 2023; 14:1269960.
PMID: 37936689 PMC: 10627157. DOI: 10.3389/fimmu.2023.1269960.